| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 1.020.749.006 $ | -91.309.644 $ | +10,7 % | 5 | 1.112.058.650 $ | -20.540.765 $ | +3,7 % | 4 | 1.863.221.739 $ | +1.863.221.739 $ | 4 | |||||
| Waystar Holding Corp. | WAY | → 0 | Stark | 599.843.226 $ | -214.958.336 $ | -26,4 % | 1 | 814.801.562 $ | -128.626.689 $ | -13,6 % | 1 | 943.428.251 $ | +943.428.251 $ | 1 | |
| Kodiak Gas Services, Inc. | KGS | → 0 | Neutral | 730.622.324 $ | +730.622.324 $ | 1 | |||||||||
| Oculis Holding AG | OCS | → 0 | Stark | 156.888.817 $ | +39.059.946 $ | +33,1 % | 1 | 117.828.871 $ | +14.101.702 $ | +13,6 % | 1 | 103.727.169 $ | +103.727.169 $ | 1 | |
| Evommune, Inc. | EVMN | → 0 | Neutral | 113.332.263 $ | +28.936.946 $ | +34,3 % | 1 | 84.395.317 $ | +84.395.317 $ | 1 | |||||
| Pharvaris N.V. | PHVS | → 0 | Neutral | 96.745.204 $ | +1.712.304 $ | +1,8 % | 1 | 95.032.900 $ | +9.588.905 $ | +11,2 % | 1 | 85.443.995 $ | +85.443.995 $ | 1 | |
| Agomab Therapeutics NV | AGMB | → 0 | Schwach | 53.939.496 $ | +53.939.496 $ | 1 | |||||||||
| 1.020.749.006 $ | -91.309.644 $ | +10,7 % | 5 | 1.112.058.650 $ | -20.540.765 $ | +3,7 % | 4 | 1.863.221.739 $ | +1.863.221.739 $ | 4 | |||||